nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2C9—brain cancer	0.753	1	CbGaD
Arformoterol—CYP2D6—Lomustine—brain cancer	0.0687	0.569	CbGbCtD
Arformoterol—CYP2D6—Hydroxyurea—brain cancer	0.0521	0.431	CbGbCtD
Arformoterol—Cerebral infarction—Carmustine—brain cancer	0.00249	0.0218	CcSEcCtD
Arformoterol—Neoplasm—Lomustine—brain cancer	0.00185	0.0162	CcSEcCtD
Arformoterol—Metabolic acidosis—Etoposide—brain cancer	0.00159	0.0139	CcSEcCtD
Arformoterol—Dysphonia—Procarbazine—brain cancer	0.00158	0.0138	CcSEcCtD
Arformoterol—Formoterol—CYP2C9—brain cancer	0.00155	1	CrCbGaD
Arformoterol—Nocturia—Procarbazine—brain cancer	0.0014	0.0123	CcSEcCtD
Arformoterol—Oral candidiasis—Carmustine—brain cancer	0.00128	0.0112	CcSEcCtD
Arformoterol—Melaena—Procarbazine—brain cancer	0.00127	0.0111	CcSEcCtD
Arformoterol—Oral candidiasis—Temozolomide—brain cancer	0.00123	0.0108	CcSEcCtD
Arformoterol—Hypokinesia—Carmustine—brain cancer	0.0012	0.0105	CcSEcCtD
Arformoterol—Lung disorder—Temozolomide—brain cancer	0.00111	0.00972	CcSEcCtD
Arformoterol—Herpes zoster—Temozolomide—brain cancer	0.00104	0.00913	CcSEcCtD
Arformoterol—Abscess—Carmustine—brain cancer	0.00103	0.00899	CcSEcCtD
Arformoterol—Injection site pain—Carmustine—brain cancer	0.000993	0.00872	CcSEcCtD
Arformoterol—Visual impairment—Lomustine—brain cancer	0.000988	0.00867	CcSEcCtD
Arformoterol—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.000927	0.0852	CbGpPWpGaD
Arformoterol—Neoplasm—Hydroxyurea—brain cancer	0.000907	0.00796	CcSEcCtD
Arformoterol—Viral infection—Temozolomide—brain cancer	0.000868	0.00761	CcSEcCtD
Arformoterol—Leukocytosis—Carmustine—brain cancer	0.000863	0.00757	CcSEcCtD
Arformoterol—Herpes simplex—Temozolomide—brain cancer	0.000851	0.00746	CcSEcCtD
Arformoterol—Infection—Carboplatin—brain cancer	0.000827	0.00726	CcSEcCtD
Arformoterol—Angina pectoris—Procarbazine—brain cancer	0.000792	0.00695	CcSEcCtD
Arformoterol—Candida infection—Carmustine—brain cancer	0.000774	0.00679	CcSEcCtD
Arformoterol—Candida infection—Temozolomide—brain cancer	0.000748	0.00657	CcSEcCtD
Arformoterol—Neoplasm—Carmustine—brain cancer	0.000733	0.00643	CcSEcCtD
Arformoterol—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00073	0.067	CbGpPWpGaD
Arformoterol—Infection—Lomustine—brain cancer	0.000724	0.00635	CcSEcCtD
Arformoterol—Pain—Carboplatin—brain cancer	0.000712	0.00625	CcSEcCtD
Arformoterol—Neoplasm—Temozolomide—brain cancer	0.000709	0.00622	CcSEcCtD
Arformoterol—Abnormal vision—Carmustine—brain cancer	0.000707	0.00621	CcSEcCtD
Arformoterol—Skin discolouration—Etoposide—brain cancer	0.000694	0.00609	CcSEcCtD
Arformoterol—Haematuria—Procarbazine—brain cancer	0.000691	0.00607	CcSEcCtD
Arformoterol—Abnormal vision—Temozolomide—brain cancer	0.000684	0.006	CcSEcCtD
Arformoterol—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000664	0.061	CbGpPWpGaD
Arformoterol—Body temperature increased—Carboplatin—brain cancer	0.000658	0.00578	CcSEcCtD
Arformoterol—Inflammation—Etoposide—brain cancer	0.000647	0.00567	CcSEcCtD
Arformoterol—Gastroenteritis—Temozolomide—brain cancer	0.000642	0.00563	CcSEcCtD
Arformoterol—Injury—Carmustine—brain cancer	0.000641	0.00562	CcSEcCtD
Arformoterol—Nasal congestion—Temozolomide—brain cancer	0.000625	0.00548	CcSEcCtD
Arformoterol—Candida infection—Etoposide—brain cancer	0.000599	0.00525	CcSEcCtD
Arformoterol—Arrhythmia—Procarbazine—brain cancer	0.000582	0.0051	CcSEcCtD
Arformoterol—Body temperature increased—Lomustine—brain cancer	0.000576	0.00505	CcSEcCtD
Arformoterol—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.000575	0.0528	CbGpPWpGaD
Arformoterol—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000565	0.052	CbGpPWpGaD
Arformoterol—Tension—Procarbazine—brain cancer	0.000556	0.00488	CcSEcCtD
Arformoterol—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000553	0.0508	CbGpPWpGaD
Arformoterol—Nervousness—Procarbazine—brain cancer	0.00055	0.00483	CcSEcCtD
Arformoterol—Hypokalaemia—Carmustine—brain cancer	0.000536	0.0047	CcSEcCtD
Arformoterol—Tremor—Procarbazine—brain cancer	0.000531	0.00466	CcSEcCtD
Arformoterol—Dehydration—Temozolomide—brain cancer	0.000529	0.00464	CcSEcCtD
Arformoterol—Dry skin—Temozolomide—brain cancer	0.000522	0.00458	CcSEcCtD
Arformoterol—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00052	0.0478	CbGpPWpGaD
Arformoterol—Hypokalaemia—Temozolomide—brain cancer	0.000518	0.00454	CcSEcCtD
Arformoterol—Cardiac failure congestive—Etoposide—brain cancer	0.000502	0.00441	CcSEcCtD
Arformoterol—Cough—Procarbazine—brain cancer	0.000495	0.00434	CcSEcCtD
Arformoterol—Hypertension—Procarbazine—brain cancer	0.000489	0.00429	CcSEcCtD
Arformoterol—Myalgia—Procarbazine—brain cancer	0.000482	0.00423	CcSEcCtD
Arformoterol—Arthralgia—Procarbazine—brain cancer	0.000482	0.00423	CcSEcCtD
Arformoterol—Anxiety—Procarbazine—brain cancer	0.000481	0.00422	CcSEcCtD
Arformoterol—Bronchitis—Temozolomide—brain cancer	0.000473	0.00415	CcSEcCtD
Arformoterol—Dry mouth—Procarbazine—brain cancer	0.000472	0.00414	CcSEcCtD
Arformoterol—Vomiting—Lomustine—brain cancer	0.000463	0.00406	CcSEcCtD
Arformoterol—Oedema—Procarbazine—brain cancer	0.000463	0.00406	CcSEcCtD
Arformoterol—Infection—Procarbazine—brain cancer	0.00046	0.00403	CcSEcCtD
Arformoterol—Hyperglycaemia—Carmustine—brain cancer	0.000459	0.00403	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Temozolomide—brain cancer	0.000457	0.00401	CcSEcCtD
Arformoterol—Tachycardia—Procarbazine—brain cancer	0.000451	0.00396	CcSEcCtD
Arformoterol—Hyperglycaemia—Temozolomide—brain cancer	0.000444	0.00389	CcSEcCtD
Arformoterol—Urinary tract infection—Carmustine—brain cancer	0.000441	0.00387	CcSEcCtD
Arformoterol—Nausea—Lomustine—brain cancer	0.000433	0.0038	CcSEcCtD
Arformoterol—Hypotension—Procarbazine—brain cancer	0.000432	0.00379	CcSEcCtD
Arformoterol—Urinary tract infection—Temozolomide—brain cancer	0.000426	0.00374	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000421	0.0037	CcSEcCtD
Arformoterol—Insomnia—Procarbazine—brain cancer	0.000418	0.00367	CcSEcCtD
Arformoterol—Sinusitis—Temozolomide—brain cancer	0.000411	0.00361	CcSEcCtD
Arformoterol—Somnolence—Procarbazine—brain cancer	0.000411	0.00361	CcSEcCtD
Arformoterol—Cramp muscle—Etoposide—brain cancer	0.00041	0.0036	CcSEcCtD
Arformoterol—Ill-defined disorder—Hydroxyurea—brain cancer	0.000407	0.00357	CcSEcCtD
Arformoterol—Oedema peripheral—Carmustine—brain cancer	0.000401	0.00352	CcSEcCtD
Arformoterol—Connective tissue disorder—Carmustine—brain cancer	0.0004	0.00351	CcSEcCtD
Arformoterol—Fatigue—Procarbazine—brain cancer	0.000399	0.0035	CcSEcCtD
Arformoterol—Malaise—Hydroxyurea—brain cancer	0.000396	0.00347	CcSEcCtD
Arformoterol—Constipation—Procarbazine—brain cancer	0.000396	0.00347	CcSEcCtD
Arformoterol—Pain—Procarbazine—brain cancer	0.000396	0.00347	CcSEcCtD
Arformoterol—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000395	0.0363	CbGpPWpGaD
Arformoterol—Visual impairment—Carmustine—brain cancer	0.000393	0.00344	CcSEcCtD
Arformoterol—Pharyngitis—Temozolomide—brain cancer	0.000391	0.00343	CcSEcCtD
Arformoterol—Urinary tract disorder—Temozolomide—brain cancer	0.000389	0.00341	CcSEcCtD
Arformoterol—Oedema peripheral—Temozolomide—brain cancer	0.000388	0.0034	CcSEcCtD
Arformoterol—Bronchospasm—Etoposide—brain cancer	0.000387	0.0034	CcSEcCtD
Arformoterol—Connective tissue disorder—Temozolomide—brain cancer	0.000387	0.00339	CcSEcCtD
Arformoterol—Urethral disorder—Temozolomide—brain cancer	0.000386	0.00339	CcSEcCtD
Arformoterol—Feeling abnormal—Procarbazine—brain cancer	0.000381	0.00334	CcSEcCtD
Arformoterol—Visual impairment—Temozolomide—brain cancer	0.000379	0.00333	CcSEcCtD
Arformoterol—Gastrointestinal pain—Procarbazine—brain cancer	0.000378	0.00332	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000371	0.00325	CcSEcCtD
Arformoterol—Discomfort—Hydroxyurea—brain cancer	0.000369	0.00324	CcSEcCtD
Arformoterol—Urticaria—Procarbazine—brain cancer	0.000367	0.00322	CcSEcCtD
Arformoterol—Body temperature increased—Procarbazine—brain cancer	0.000366	0.00321	CcSEcCtD
Arformoterol—Abdominal pain—Procarbazine—brain cancer	0.000366	0.00321	CcSEcCtD
Arformoterol—Cardiac disorder—Temozolomide—brain cancer	0.000365	0.00321	CcSEcCtD
Arformoterol—Arrhythmia—Carmustine—brain cancer	0.000364	0.00319	CcSEcCtD
Arformoterol—Oedema—Hydroxyurea—brain cancer	0.000358	0.00314	CcSEcCtD
Arformoterol—Mental disorder—Carmustine—brain cancer	0.000357	0.00313	CcSEcCtD
Arformoterol—Infection—Hydroxyurea—brain cancer	0.000356	0.00312	CcSEcCtD
Arformoterol—Immune system disorder—Temozolomide—brain cancer	0.000356	0.00312	CcSEcCtD
Arformoterol—Mediastinal disorder—Temozolomide—brain cancer	0.000355	0.00311	CcSEcCtD
Arformoterol—Malnutrition—Carmustine—brain cancer	0.000355	0.00311	CcSEcCtD
Arformoterol—Nervous system disorder—Hydroxyurea—brain cancer	0.000351	0.00308	CcSEcCtD
Arformoterol—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000351	0.0322	CbGpPWpGaD
Arformoterol—Skin disorder—Hydroxyurea—brain cancer	0.000348	0.00305	CcSEcCtD
Arformoterol—Acute coronary syndrome—Etoposide—brain cancer	0.000346	0.00303	CcSEcCtD
Arformoterol—Mental disorder—Temozolomide—brain cancer	0.000345	0.00303	CcSEcCtD
Arformoterol—Myocardial infarction—Etoposide—brain cancer	0.000344	0.00302	CcSEcCtD
Arformoterol—Back pain—Carmustine—brain cancer	0.000343	0.00301	CcSEcCtD
Arformoterol—Malnutrition—Temozolomide—brain cancer	0.000343	0.00301	CcSEcCtD
Arformoterol—Hypersensitivity—Procarbazine—brain cancer	0.000341	0.00299	CcSEcCtD
Arformoterol—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000337	0.031	CbGpPWpGaD
Arformoterol—Dysgeusia—Temozolomide—brain cancer	0.000336	0.00294	CcSEcCtD
Arformoterol—Tremor—Carmustine—brain cancer	0.000332	0.00291	CcSEcCtD
Arformoterol—Asthenia—Procarbazine—brain cancer	0.000332	0.00291	CcSEcCtD
Arformoterol—Back pain—Temozolomide—brain cancer	0.000331	0.00291	CcSEcCtD
Arformoterol—Pruritus—Procarbazine—brain cancer	0.000327	0.00287	CcSEcCtD
Arformoterol—Agitation—Carmustine—brain cancer	0.000326	0.00286	CcSEcCtD
Arformoterol—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000322	0.0296	CbGpPWpGaD
Arformoterol—Tremor—Temozolomide—brain cancer	0.000321	0.00282	CcSEcCtD
Arformoterol—Dyspnoea—Hydroxyurea—brain cancer	0.000319	0.0028	CcSEcCtD
Arformoterol—Somnolence—Hydroxyurea—brain cancer	0.000318	0.00279	CcSEcCtD
Arformoterol—Ill-defined disorder—Temozolomide—brain cancer	0.000318	0.00279	CcSEcCtD
Arformoterol—Diarrhoea—Procarbazine—brain cancer	0.000316	0.00278	CcSEcCtD
Arformoterol—Dyspepsia—Hydroxyurea—brain cancer	0.000315	0.00276	CcSEcCtD
Arformoterol—Agitation—Temozolomide—brain cancer	0.000315	0.00276	CcSEcCtD
Arformoterol—Angioedema—Temozolomide—brain cancer	0.000313	0.00275	CcSEcCtD
Arformoterol—Urinary tract disorder—Etoposide—brain cancer	0.000311	0.00273	CcSEcCtD
Arformoterol—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00031	0.0285	CbGpPWpGaD
Arformoterol—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000309	0.00271	CcSEcCtD
Arformoterol—Malaise—Temozolomide—brain cancer	0.000309	0.00271	CcSEcCtD
Arformoterol—Urethral disorder—Etoposide—brain cancer	0.000309	0.00271	CcSEcCtD
Arformoterol—Fatigue—Hydroxyurea—brain cancer	0.000309	0.00271	CcSEcCtD
Arformoterol—Hypertension—Carmustine—brain cancer	0.000306	0.00269	CcSEcCtD
Arformoterol—Pain—Hydroxyurea—brain cancer	0.000306	0.00269	CcSEcCtD
Arformoterol—Constipation—Hydroxyurea—brain cancer	0.000306	0.00269	CcSEcCtD
Arformoterol—Dizziness—Procarbazine—brain cancer	0.000306	0.00268	CcSEcCtD
Arformoterol—Palpitations—Temozolomide—brain cancer	0.000303	0.00266	CcSEcCtD
Arformoterol—Chest pain—Carmustine—brain cancer	0.000302	0.00265	CcSEcCtD
Arformoterol—Myalgia—Carmustine—brain cancer	0.000302	0.00265	CcSEcCtD
Arformoterol—Anxiety—Carmustine—brain cancer	0.000301	0.00264	CcSEcCtD
Arformoterol—Cough—Temozolomide—brain cancer	0.000299	0.00262	CcSEcCtD
Arformoterol—Hypertension—Temozolomide—brain cancer	0.000296	0.0026	CcSEcCtD
Arformoterol—Feeling abnormal—Hydroxyurea—brain cancer	0.000295	0.00259	CcSEcCtD
Arformoterol—Vomiting—Procarbazine—brain cancer	0.000294	0.00258	CcSEcCtD
Arformoterol—Cardiac disorder—Etoposide—brain cancer	0.000292	0.00256	CcSEcCtD
Arformoterol—Myalgia—Temozolomide—brain cancer	0.000292	0.00256	CcSEcCtD
Arformoterol—Arthralgia—Temozolomide—brain cancer	0.000292	0.00256	CcSEcCtD
Arformoterol—Rash—Procarbazine—brain cancer	0.000292	0.00256	CcSEcCtD
Arformoterol—Dermatitis—Procarbazine—brain cancer	0.000291	0.00256	CcSEcCtD
Arformoterol—Anxiety—Temozolomide—brain cancer	0.000291	0.00255	CcSEcCtD
Arformoterol—Headache—Procarbazine—brain cancer	0.00029	0.00254	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00029	0.00254	CcSEcCtD
Arformoterol—Oedema—Carmustine—brain cancer	0.000289	0.00254	CcSEcCtD
Arformoterol—Discomfort—Temozolomide—brain cancer	0.000288	0.00253	CcSEcCtD
Arformoterol—Infection—Carmustine—brain cancer	0.000287	0.00252	CcSEcCtD
Arformoterol—Dry mouth—Temozolomide—brain cancer	0.000285	0.0025	CcSEcCtD
Arformoterol—Immune system disorder—Etoposide—brain cancer	0.000284	0.0025	CcSEcCtD
Arformoterol—Mediastinal disorder—Etoposide—brain cancer	0.000284	0.00249	CcSEcCtD
Arformoterol—Body temperature increased—Hydroxyurea—brain cancer	0.000283	0.00248	CcSEcCtD
Arformoterol—Tachycardia—Carmustine—brain cancer	0.000282	0.00248	CcSEcCtD
Arformoterol—Anaphylactic shock—Temozolomide—brain cancer	0.00028	0.00245	CcSEcCtD
Arformoterol—Oedema—Temozolomide—brain cancer	0.00028	0.00245	CcSEcCtD
Arformoterol—Infection—Temozolomide—brain cancer	0.000278	0.00244	CcSEcCtD
Arformoterol—Nausea—Procarbazine—brain cancer	0.000275	0.00241	CcSEcCtD
Arformoterol—Nervous system disorder—Temozolomide—brain cancer	0.000274	0.00241	CcSEcCtD
Arformoterol—Skin disorder—Temozolomide—brain cancer	0.000272	0.00238	CcSEcCtD
Arformoterol—Hypotension—Carmustine—brain cancer	0.00027	0.00237	CcSEcCtD
Arformoterol—Dysgeusia—Etoposide—brain cancer	0.000268	0.00236	CcSEcCtD
Arformoterol—Back pain—Etoposide—brain cancer	0.000265	0.00233	CcSEcCtD
Arformoterol—Hypersensitivity—Hydroxyurea—brain cancer	0.000264	0.00231	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Carmustine—brain cancer	0.000264	0.00231	CcSEcCtD
Arformoterol—Muscle spasms—Etoposide—brain cancer	0.000264	0.00231	CcSEcCtD
Arformoterol—Insomnia—Carmustine—brain cancer	0.000262	0.0023	CcSEcCtD
Arformoterol—Dyspnoea—Carmustine—brain cancer	0.000258	0.00226	CcSEcCtD
Arformoterol—Somnolence—Carmustine—brain cancer	0.000257	0.00226	CcSEcCtD
Arformoterol—Asthenia—Hydroxyurea—brain cancer	0.000257	0.00225	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000255	0.00224	CcSEcCtD
Arformoterol—Ill-defined disorder—Etoposide—brain cancer	0.000254	0.00223	CcSEcCtD
Arformoterol—Insomnia—Temozolomide—brain cancer	0.000253	0.00222	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Carmustine—brain cancer	0.00025	0.00219	CcSEcCtD
Arformoterol—Dyspnoea—Temozolomide—brain cancer	0.000249	0.00219	CcSEcCtD
Arformoterol—Somnolence—Temozolomide—brain cancer	0.000249	0.00218	CcSEcCtD
Arformoterol—Pain—Carmustine—brain cancer	0.000247	0.00217	CcSEcCtD
Arformoterol—Constipation—Carmustine—brain cancer	0.000247	0.00217	CcSEcCtD
Arformoterol—Malaise—Etoposide—brain cancer	0.000247	0.00217	CcSEcCtD
Arformoterol—Dyspepsia—Temozolomide—brain cancer	0.000246	0.00216	CcSEcCtD
Arformoterol—Diarrhoea—Hydroxyurea—brain cancer	0.000245	0.00215	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Temozolomide—brain cancer	0.000241	0.00212	CcSEcCtD
Arformoterol—Fatigue—Temozolomide—brain cancer	0.000241	0.00212	CcSEcCtD
Arformoterol—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000241	0.0221	CbGpPWpGaD
Arformoterol—Cough—Etoposide—brain cancer	0.000239	0.0021	CcSEcCtD
Arformoterol—Constipation—Temozolomide—brain cancer	0.000239	0.0021	CcSEcCtD
Arformoterol—Pain—Temozolomide—brain cancer	0.000239	0.0021	CcSEcCtD
Arformoterol—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000239	0.0219	CbGpPWpGaD
Arformoterol—Feeling abnormal—Carmustine—brain cancer	0.000238	0.00209	CcSEcCtD
Arformoterol—Hypertension—Etoposide—brain cancer	0.000237	0.00208	CcSEcCtD
Arformoterol—Dizziness—Hydroxyurea—brain cancer	0.000237	0.00208	CcSEcCtD
Arformoterol—Gastrointestinal pain—Carmustine—brain cancer	0.000237	0.00208	CcSEcCtD
Arformoterol—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000236	0.0216	CbGpPWpGaD
Arformoterol—Chest pain—Etoposide—brain cancer	0.000233	0.00205	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000232	0.00203	CcSEcCtD
Arformoterol—Discomfort—Etoposide—brain cancer	0.000231	0.00202	CcSEcCtD
Arformoterol—Feeling abnormal—Temozolomide—brain cancer	0.00023	0.00202	CcSEcCtD
Arformoterol—Body temperature increased—Carmustine—brain cancer	0.000229	0.00201	CcSEcCtD
Arformoterol—Abdominal pain—Carmustine—brain cancer	0.000229	0.00201	CcSEcCtD
Arformoterol—Gastrointestinal pain—Temozolomide—brain cancer	0.000229	0.00201	CcSEcCtD
Arformoterol—Vomiting—Hydroxyurea—brain cancer	0.000228	0.002	CcSEcCtD
Arformoterol—Rash—Hydroxyurea—brain cancer	0.000226	0.00198	CcSEcCtD
Arformoterol—Dermatitis—Hydroxyurea—brain cancer	0.000225	0.00198	CcSEcCtD
Arformoterol—Headache—Hydroxyurea—brain cancer	0.000224	0.00197	CcSEcCtD
Arformoterol—Anaphylactic shock—Etoposide—brain cancer	0.000224	0.00196	CcSEcCtD
Arformoterol—Infection—Etoposide—brain cancer	0.000222	0.00195	CcSEcCtD
Arformoterol—Urticaria—Temozolomide—brain cancer	0.000222	0.00195	CcSEcCtD
Arformoterol—Body temperature increased—Temozolomide—brain cancer	0.000221	0.00194	CcSEcCtD
Arformoterol—Abdominal pain—Temozolomide—brain cancer	0.000221	0.00194	CcSEcCtD
Arformoterol—Tachycardia—Etoposide—brain cancer	0.000218	0.00192	CcSEcCtD
Arformoterol—Skin disorder—Etoposide—brain cancer	0.000217	0.00191	CcSEcCtD
Arformoterol—Hypersensitivity—Carmustine—brain cancer	0.000213	0.00187	CcSEcCtD
Arformoterol—Nausea—Hydroxyurea—brain cancer	0.000213	0.00187	CcSEcCtD
Arformoterol—Hypotension—Etoposide—brain cancer	0.000209	0.00183	CcSEcCtD
Arformoterol—Asthenia—Carmustine—brain cancer	0.000208	0.00182	CcSEcCtD
Arformoterol—Hypersensitivity—Temozolomide—brain cancer	0.000206	0.00181	CcSEcCtD
Arformoterol—Asthenia—Temozolomide—brain cancer	0.000201	0.00176	CcSEcCtD
Arformoterol—Dyspnoea—Etoposide—brain cancer	0.000199	0.00175	CcSEcCtD
Arformoterol—Somnolence—Etoposide—brain cancer	0.000199	0.00175	CcSEcCtD
Arformoterol—Diarrhoea—Carmustine—brain cancer	0.000198	0.00174	CcSEcCtD
Arformoterol—Pruritus—Temozolomide—brain cancer	0.000198	0.00174	CcSEcCtD
Arformoterol—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000194	0.0178	CbGpPWpGaD
Arformoterol—Gastrointestinal disorder—Etoposide—brain cancer	0.000193	0.0017	CcSEcCtD
Arformoterol—Fatigue—Etoposide—brain cancer	0.000193	0.00169	CcSEcCtD
Arformoterol—Dizziness—Carmustine—brain cancer	0.000191	0.00168	CcSEcCtD
Arformoterol—Pain—Etoposide—brain cancer	0.000191	0.00168	CcSEcCtD
Arformoterol—Constipation—Etoposide—brain cancer	0.000191	0.00168	CcSEcCtD
Arformoterol—Diarrhoea—Temozolomide—brain cancer	0.000191	0.00168	CcSEcCtD
Arformoterol—Dizziness—Temozolomide—brain cancer	0.000185	0.00162	CcSEcCtD
Arformoterol—Feeling abnormal—Etoposide—brain cancer	0.000184	0.00162	CcSEcCtD
Arformoterol—Vomiting—Carmustine—brain cancer	0.000184	0.00161	CcSEcCtD
Arformoterol—Gastrointestinal pain—Etoposide—brain cancer	0.000183	0.00161	CcSEcCtD
Arformoterol—Rash—Carmustine—brain cancer	0.000182	0.0016	CcSEcCtD
Arformoterol—Dermatitis—Carmustine—brain cancer	0.000182	0.0016	CcSEcCtD
Arformoterol—Headache—Carmustine—brain cancer	0.000181	0.00159	CcSEcCtD
Arformoterol—Vomiting—Temozolomide—brain cancer	0.000178	0.00156	CcSEcCtD
Arformoterol—Urticaria—Etoposide—brain cancer	0.000178	0.00156	CcSEcCtD
Arformoterol—Body temperature increased—Etoposide—brain cancer	0.000177	0.00155	CcSEcCtD
Arformoterol—Abdominal pain—Etoposide—brain cancer	0.000177	0.00155	CcSEcCtD
Arformoterol—Rash—Temozolomide—brain cancer	0.000176	0.00155	CcSEcCtD
Arformoterol—Dermatitis—Temozolomide—brain cancer	0.000176	0.00155	CcSEcCtD
Arformoterol—Headache—Temozolomide—brain cancer	0.000175	0.00154	CcSEcCtD
Arformoterol—Nausea—Carmustine—brain cancer	0.000172	0.00151	CcSEcCtD
Arformoterol—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000168	0.0155	CbGpPWpGaD
Arformoterol—Nausea—Temozolomide—brain cancer	0.000166	0.00146	CcSEcCtD
Arformoterol—Hypersensitivity—Etoposide—brain cancer	0.000165	0.00145	CcSEcCtD
Arformoterol—Asthenia—Etoposide—brain cancer	0.000161	0.00141	CcSEcCtD
Arformoterol—Pruritus—Etoposide—brain cancer	0.000158	0.00139	CcSEcCtD
Arformoterol—Diarrhoea—Etoposide—brain cancer	0.000153	0.00134	CcSEcCtD
Arformoterol—Dizziness—Etoposide—brain cancer	0.000148	0.0013	CcSEcCtD
Arformoterol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000146	0.0134	CbGpPWpGaD
Arformoterol—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000144	0.0132	CbGpPWpGaD
Arformoterol—Vomiting—Etoposide—brain cancer	0.000142	0.00125	CcSEcCtD
Arformoterol—Rash—Etoposide—brain cancer	0.000141	0.00124	CcSEcCtD
Arformoterol—Dermatitis—Etoposide—brain cancer	0.000141	0.00124	CcSEcCtD
Arformoterol—Headache—Etoposide—brain cancer	0.00014	0.00123	CcSEcCtD
Arformoterol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000134	0.0123	CbGpPWpGaD
Arformoterol—Nausea—Etoposide—brain cancer	0.000133	0.00117	CcSEcCtD
Arformoterol—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000132	0.0121	CbGpPWpGaD
Arformoterol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000118	0.0108	CbGpPWpGaD
Arformoterol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000109	0.01	CbGpPWpGaD
Arformoterol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000109	0.00997	CbGpPWpGaD
Arformoterol—ADRB2—GPCRs, Other—SMO—brain cancer	0.000105	0.00964	CbGpPWpGaD
Arformoterol—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000103	0.00944	CbGpPWpGaD
Arformoterol—CYP2C19—Biological oxidations—CYP2C9—brain cancer	6.27e-05	0.00576	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—PTCH2—brain cancer	6.23e-05	0.00572	CbGpPWpGaD
Arformoterol—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	6.18e-05	0.00568	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—PTCH2—brain cancer	6.09e-05	0.0056	CbGpPWpGaD
Arformoterol—ADRB2—Arf6 signaling events—EGFR—brain cancer	5.87e-05	0.00539	CbGpPWpGaD
Arformoterol—ADRB2—Arf6 trafficking events—CTNNB1—brain cancer	5.85e-05	0.00538	CbGpPWpGaD
Arformoterol—CYP2D6—Biological oxidations—CYP2C9—brain cancer	5.76e-05	0.0053	CbGpPWpGaD
Arformoterol—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	5.69e-05	0.00522	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—OR14C36—brain cancer	5.46e-05	0.00502	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—OR4C12—brain cancer	5.46e-05	0.00502	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—OR4C12—brain cancer	5.34e-05	0.00491	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—OR14C36—brain cancer	5.34e-05	0.00491	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—OR14C36—brain cancer	4.96e-05	0.00456	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—OR4C12—brain cancer	4.96e-05	0.00456	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—OR4C12—brain cancer	4.85e-05	0.00446	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—OR14C36—brain cancer	4.85e-05	0.00446	CbGpPWpGaD
Arformoterol—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	4.61e-05	0.00424	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—SHH—brain cancer	3.21e-05	0.00295	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PTCH2—brain cancer	3.2e-05	0.00294	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—SHH—brain cancer	3.14e-05	0.00288	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PTCH2—brain cancer	3.13e-05	0.00287	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—SMO—brain cancer	3.04e-05	0.00279	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—PTCH1—brain cancer	3.04e-05	0.00279	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—SMO—brain cancer	2.98e-05	0.00273	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—PTCH1—brain cancer	2.98e-05	0.00273	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—OR14C36—brain cancer	2.93e-05	0.00269	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—OR4C12—brain cancer	2.93e-05	0.00269	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—OR4C12—brain cancer	2.87e-05	0.00263	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—OR14C36—brain cancer	2.87e-05	0.00263	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—ABR—brain cancer	2.76e-05	0.00254	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—ABR—brain cancer	2.7e-05	0.00248	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—ABR—brain cancer	2.51e-05	0.0023	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—DTX2—brain cancer	2.49e-05	0.00229	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—ABR—brain cancer	2.45e-05	0.00225	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—DTX2—brain cancer	2.44e-05	0.00224	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.41e-05	0.00221	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PTCH2—brain cancer	1.89e-05	0.00173	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PTCH2—brain cancer	1.85e-05	0.0017	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HES5—brain cancer	1.83e-05	0.00168	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HES5—brain cancer	1.79e-05	0.00164	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—STRADA—brain cancer	1.78e-05	0.00163	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.76e-05	0.00162	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CYP2C9—brain cancer	1.76e-05	0.00162	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—TRPC6—brain cancer	1.75e-05	0.00161	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—STRADA—brain cancer	1.74e-05	0.0016	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—TRPC6—brain cancer	1.71e-05	0.00157	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—SHH—brain cancer	1.65e-05	0.00151	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—SHH—brain cancer	1.61e-05	0.00148	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.6e-05	0.00147	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—TRPC6—brain cancer	1.59e-05	0.00146	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PTCH1—brain cancer	1.56e-05	0.00143	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—SMO—brain cancer	1.56e-05	0.00143	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—TRPC6—brain cancer	1.55e-05	0.00143	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—SMO—brain cancer	1.53e-05	0.0014	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PTCH1—brain cancer	1.53e-05	0.0014	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—BSG—brain cancer	1.49e-05	0.00137	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ABR—brain cancer	1.48e-05	0.00136	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ABR—brain cancer	1.45e-05	0.00133	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GLI2—brain cancer	1.43e-05	0.00131	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GLI2—brain cancer	1.4e-05	0.00129	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GLI1—brain cancer	1.35e-05	0.00124	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GLI1—brain cancer	1.32e-05	0.00121	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—VAV1—brain cancer	1.31e-05	0.0012	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—IDH1—brain cancer	1.29e-05	0.00118	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—VAV1—brain cancer	1.28e-05	0.00118	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SUFU—brain cancer	1.28e-05	0.00117	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SUFU—brain cancer	1.25e-05	0.00115	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GFAP—brain cancer	1.23e-05	0.00113	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GFAP—brain cancer	1.2e-05	0.00111	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—VAV1—brain cancer	1.19e-05	0.00109	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HEY1—brain cancer	1.17e-05	0.00107	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—VAV1—brain cancer	1.16e-05	0.00107	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—DLL1—brain cancer	1.14e-05	0.00105	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HEY1—brain cancer	1.14e-05	0.00105	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—DLL1—brain cancer	1.12e-05	0.00103	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYP2C9—brain cancer	1.07e-05	0.000985	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ENO2—brain cancer	1.02e-05	0.000934	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CYP2C9—brain cancer	9.86e-06	0.000906	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SHH—brain cancer	9.73e-06	0.000894	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SHH—brain cancer	9.51e-06	0.000874	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TRPC6—brain cancer	9.38e-06	0.000862	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SMO—brain cancer	9.22e-06	0.000847	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PTCH1—brain cancer	9.22e-06	0.000847	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TRPC6—brain cancer	9.17e-06	0.000843	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—BSG—brain cancer	9.11e-06	0.000837	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PTCH1—brain cancer	9.02e-06	0.000829	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SMO—brain cancer	9.02e-06	0.000829	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—BSG—brain cancer	8.38e-06	0.00077	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—PIK3CG—brain cancer	8.32e-06	0.000764	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—BSG—brain cancer	8.31e-06	0.000763	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—PIK3CG—brain cancer	8.14e-06	0.000747	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—IDH1—brain cancer	7.84e-06	0.00072	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PIK3CG—brain cancer	7.55e-06	0.000694	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PIK3CG—brain cancer	7.39e-06	0.000679	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOTCH2—brain cancer	7.37e-06	0.000677	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOTCH2—brain cancer	7.21e-06	0.000662	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—IDH1—brain cancer	7.21e-06	0.000662	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—IDH1—brain cancer	7.15e-06	0.000657	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—VAV1—brain cancer	7.03e-06	0.000646	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—VAV1—brain cancer	6.87e-06	0.000632	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.38e-06	0.000586	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ENO2—brain cancer	6.19e-06	0.000569	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HES1—brain cancer	6.04e-06	0.000555	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HES1—brain cancer	5.91e-06	0.000543	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—IL2—brain cancer	5.85e-06	0.000538	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.82e-06	0.000535	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PDGFRA—brain cancer	5.75e-06	0.000529	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—IL2—brain cancer	5.73e-06	0.000526	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ENO2—brain cancer	5.7e-06	0.000524	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ENO2—brain cancer	5.65e-06	0.000519	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PDGFRA—brain cancer	5.63e-06	0.000517	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SPP1—brain cancer	5.59e-06	0.000513	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SPP1—brain cancer	5.46e-06	0.000502	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL2—brain cancer	5.31e-06	0.000488	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL2—brain cancer	5.2e-06	0.000478	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IRS2—brain cancer	5.05e-06	0.000464	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IRS2—brain cancer	4.94e-06	0.000454	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PIK3CG—brain cancer	4.66e-06	0.000428	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APC—brain cancer	4.46e-06	0.00041	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PIK3CG—brain cancer	4.46e-06	0.00041	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APC—brain cancer	4.36e-06	0.000401	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PIK3CG—brain cancer	4.36e-06	0.000401	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—EGFR—brain cancer	4.06e-06	0.000373	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—EGFR—brain cancer	3.98e-06	0.000365	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—RELA—brain cancer	3.49e-06	0.00032	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ERBB2—brain cancer	3.46e-06	0.000318	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—RELA—brain cancer	3.41e-06	0.000313	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ERBB2—brain cancer	3.39e-06	0.000311	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL2—brain cancer	3.14e-06	0.000288	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL2—brain cancer	3.07e-06	0.000282	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCND1—brain cancer	3.06e-06	0.000281	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CTNNB1—brain cancer	3.03e-06	0.000278	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCND1—brain cancer	2.99e-06	0.000275	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CTNNB1—brain cancer	2.96e-06	0.000272	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PIK3CG—brain cancer	2.84e-06	0.000261	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—VEGFA—brain cancer	2.67e-06	0.000245	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—STAT3—brain cancer	2.64e-06	0.000243	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PIK3CG—brain cancer	2.61e-06	0.00024	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—VEGFA—brain cancer	2.61e-06	0.00024	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PIK3CG—brain cancer	2.59e-06	0.000238	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—STAT3—brain cancer	2.58e-06	0.000237	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MYC—brain cancer	2.45e-06	0.000226	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MYC—brain cancer	2.4e-06	0.000221	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—EGFR—brain cancer	2.4e-06	0.000221	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—EGFR—brain cancer	2.35e-06	0.000216	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TP53—brain cancer	2.02e-06	0.000185	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TP53—brain cancer	1.97e-06	0.000181	CbGpPWpGaD
